Cargando…
The Long-Lasting Protective Effect of HGF in Cardiomyoblasts Exposed to Doxorubicin Requires a Positive Feed-Forward Loop Mediated by Erk1,2-Timp1-Stat3
Previous studies showed that the hepatocyte growth factor (HGF)–Met receptor axis plays long-lasting cardioprotection against doxorubicin anti-cancer therapy. Here, we explored the mechanism(s) underlying the HGF protective effect. DNA damage was monitored by histone H2AX phosphorylation and apoptos...
Autores principales: | Gallo, Simona, Spilinga, Martina, Casanova, Elena, Bonzano, Alessandro, Boccaccio, Carla, Comoglio, Paolo Maria, Crepaldi, Tiziana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432797/ https://www.ncbi.nlm.nih.gov/pubmed/32722178 http://dx.doi.org/10.3390/ijms21155258 |
Ejemplares similares
-
Activation of the MET receptor attenuates doxorubicin‐induced cardiotoxicity in vivo and in vitro
por: Gallo, Simona, et al.
Publicado: (2020) -
ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy
por: Gallo, Simona, et al.
Publicado: (2019) -
Agonist antibodies activating the Met receptor protect cardiomyoblasts from cobalt chloride-induced apoptosis and autophagy
por: Gallo, S, et al.
Publicado: (2014) -
HGF and MET: From Brain Development to Neurological Disorders
por: Desole, Claudia, et al.
Publicado: (2021) -
Engineering, Characterization, and Biological Evaluation of an Antibody Targeting the HGF Receptor
por: Desole, Claudia, et al.
Publicado: (2021)